Translational Awards
The British Heart Foundation’s Translational Awards fund projects advancing cardiovascular technologies from proof-of-concept to commercial readiness, emphasizing strong IP and a clear route to market.
Funder: British Heart Foundation
Due Dates (Anticipated): February 2027 (Preliminary) | August 2027 (Preliminary)
Funding Amounts: No upper limit; funding is project-dependent and typically up to 3 years, with milestone-based budgets.
Summary: Supports advancement of novel cardiovascular technologies from proof-of-concept to market readiness, emphasizing strong IP and commercial potential.
Key Information: Two-stage application; must partner with your institution’s Technology Transfer Office.
Description
The British Heart Foundation’s Translational Awards are designed to progress innovative cardiovascular research technologies along the translational pathway—from proof-of-concept through to commercial readiness. The scheme targets projects with the potential to transform human cardiovascular health, especially those addressing unmet clinical needs with a clear route to market. Eligible projects may include therapeutics, devices, diagnostics, digital solutions, or early-phase clinical studies. Applicants must demonstrate a robust intellectual property (IP) position, a structured, milestone-driven development plan, and a credible commercialisation strategy. Collaboration with institutional Technology Transfer Offices (TTOs) is mandatory to ensure the project is positioned for downstream investment and market impact.
